Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inari Medical, Inc. - Common Stock (NQ: NARI )

79.30 -0.15 (-0.19%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inari Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Dyadic International (NASDAQ:DYAI) stock increased by 28.96% to $4.63 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is... 
Via Benzinga
Why Shares of Inari Medical Are Falling Today
Dollars outpaced procedures in the second quarter. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers CohBar (NASDAQ:CWBR) stock moved upwards by 68.21% to $2.17 during Wednesday's pre-market session. The company's market cap stands at $134.0 million. The... 
Via Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
Gainers CohBar, Inc. (NASDAQ: CWBR) shares rose 78.3% to $2.30 in pre-market trading after the company reported results from the Phase 1a/1b study of CB4211 under development for... 
Via Benzinga
Earnings Scheduled For August 10, 2021
Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:... 
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
Earnings Scheduled For May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
Via Benzinga
Forget Robinhood, These 3 Healthcare Stocks Are Better Buys
Wait for pitches that are easy to hit before taking a swing. 
Via The Motley Fool
Inari Medical, Inc. (NARI) Q2 2021 Earnings Call Transcript
NARI earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
7 Stocks Moving In Tuesday's After-Hours Session
Gainers Upstart (NASDAQ: UPST) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued Q3 sales guidance above estimates. The... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers CohBar (NASDAQ:CWBR) shares incr... 
Via Benzinga
Inari Medical: Q2 Earnings Insights
Shares of Inari Medical (NASDAQ:NARI) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 143.75% year over... 
Via Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures COVID-19
3 Things I'm Looking For in Inari Medical's Earnings
What does normal look like? 
Via The Motley Fool
3 COVID Stocks That Could Soar Higher
Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021. 
Via The Motley Fool
Topics Economy
Exposures COVID-19 Economy
2 Best Buys of the Nasdaq Right Now
The overall market might be expensive, but these stocks aren't. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Investors Face New Risks In Stock Market Forecast For The Next Six Months
Stocks are at a crossroads, with new risks taking shape even as the market hits new highs. 
Via Investor's Business Daily
Topics Economy
Exposures COVID-19 Economy
Inari Medical: Return On Capital Employed Insights
Looking at Q1, Inari Medical (NASDAQ:NARI) earned $7.71 million, a 10.25% increase from the preceding quarter. Inari Medical also posted a total of $57.40 million in sales, a 18.... 
Via Benzinga
Looking Into Inari Medical's Return On Capital Employed
Looking at Q1, Inari Medical (NASDAQ:NARI) earned $7.71 million, a 10.25% increase from the preceding quarter. Inari Medical also posted a total of $57.40 million in sales, a 18.... 
Via Benzinga
Inari's Five Levers of Growth According to the CEO
Flawless execution of management's plan could lead to big gains for the stock in the years ahead. 
Via The Motley Fool
I'm Buying These 2 Stocks Amid Market Volatility
It's best to keep it simple with high-growth companies that turn a profit. 
Via The Motley Fool
3 Top Stocks to Buy for the May Market Crash
These fast-growing companies are on sale right now. 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
Inari Medical, Inc. (NARI) Q1 2021 Earnings Call Transcript
NARI earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Inari Medical Q1 Earnings
Shares of Inari Medical (NASDAQ:NARI) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 44.44% over the past... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Minerva Neurosciences (NASDAQ:NERV 
Via Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
Exposures COVID-19 Product Safety
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.